Oligo-nucleotide against Pro-opiomelanocortin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOligo-nucleotide against Pro-opiomelanocortin
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionPro-opiomelanocortin inhibitors
TargetsPro-opiomelanocortin
Therapy Area/IndicationsCushing Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEU
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDiurnal Europe Bv
China Registration ClassN/A

Develop Information

Active CompaniesDiurnal Europe Bv
Inactive CompaniesN/A
Active IndicationsCushing Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A